API SUPPLIERS

API Suppliers

30

US DMFs Filed

13

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

9,882

API Market Place

14

INTERMEDIATES

8

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

319.00

Annual Reports

0

FDF Market Place

10

EXCIPIENTS

244

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

183

USFDA Exclusivities

1

DIGITAL CONTENT

Blog #PharmaFlow

3

News

223

REF STANDARD

EDQM

3

USP

1

JP

0

Other Listed Suppliers

5

SERVICES

0

List of Suppliers

Full Screen View

Reset Filter

Price Info

Noramco

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Noroxymorphone

PDF Supplier PDF

URL Supplier Web Content

CAS Number

33522-95-1

End Use API

Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non...

Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.

CPhI North America

Attending

envelop Contact Supplier

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

List of Suppliers of Naloxone Hydrochloride intermediates listed on PharmaCompass.com

Naloxone Hydrochloride

Naloxone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 API Suppliers

13 USDMF

11 CEP/COS

1 JDMF

3 EU WC

2 KDMF

19 NDC API

19 Listed Suppliers

DEVELOPMENTS

51 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Formulations

260 Dossiers

157 FDA Orange Book

33 Europe

11 Canada

16 Australia

7 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE

FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE

FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)

FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

23 Roquette

17 SPI Pharma

16 BASF

13 Gangwal Healthcare

13 Microlex e.U

10 Corel Pharma Chem

10 Sigachi Industries

10 Actylis

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Seppic

7 Gangwal Chemicals

6 DFE Pharma

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

4 Prachin Chemical

4 Ingredion Pharma Solutions

4 Rochem International Inc

3 Kima Chemical

3 Vasa Pharmachem

2 Boai NKY Pharmaceuticals Ltd

2 Nomisma Healthcare

2 Nanjing Well Pharmaceutical

2 Seqens

2 Finar

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Pharmatrans-Sanaq

1 Pfanstiehl

1 Alcedo Pharmachem

1 Minakem

1 Zhejiang Huakang Pharmaceutical

1 Ulanqab Kema New Material

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons